Bumadizone
-
Bumadizone
structure -
-
CAS No:
3583-64-0
-
Formula:
C19H22N2O3
-
Chemical Name:
Bumadizone
-
Synonyms:
Propanedioic acid,2-butyl-,1-(1,2-diphenylhydrazide);Malonic acid,butyl-,mono(1,2-diphenylhydrazide);Propanedioic acid,butyl-,mono(1,2-diphenylhydrazide);Malonic acid,butyl-,1,2-diphenylhydrazide;N-(2-Carboxycaproyl)hydrazobenzene;Bumadizone;Bumadizon;Butylmalonic acid mono(1,2-diphenylhydrazide)
-
CAS No:
Description
ChEBI: A carbohydrazide obtained by formal condensation of one of the carboxy groups from butylmalonic acid with the hydrazino group of 1,2-diphenylhydrazine. Used (as its calcium semihydrate) for treatment of rheumatoid arthritis.
Bumadizone is a carbohydrazide obtained by formal condensation of one of the carboxy groups from butylmalonic acid with the hydrazino group of 1,2-diphenylhydrazine. Used (as its calcium semihydrate) for treatment of rheumatoid arthritis. It has a role as a non-steroidal anti-inflammatory drug and an antipyretic. It is a monocarboxylic acid and a carbohydrazide. It derives from a malonic acid. It is a conjugate acid of a bumadizone(1-).|Bumadizone has been approved for use in Germany and Austria, it is a drug with anti-inflammatory, antipyretic, and analgesic properties, and was marketed for the treatment of both rheumatoid arthritis and gout. Its use is restricted to these conditions, due to risks this drug poses.
Bumadizone Basic Attributes
326.396
326.39
222-710-1
DTXSID0022698
M - Musculo-skeletal system
2928000090
Safety Information
P264, P270, P301+P312, P330, P501
H302
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
B 64114
Computed Properties
Molecular Weight:326.4
XLogP3:4.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:8
Exact Mass:326.16304257
Monoisotopic Mass:326.16304257
Topological Polar Surface Area:69.6
Heavy Atom Count:24
Complexity:401
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes